News of the index components OMX Copenhagen 20

Index

OMXC20

DK0016268840

Market Closed - Nasdaq Copenhagen 11:05:00 2024-07-01 EDT			5-day change	1st Jan Change
2,896 ^PTS	+0.28%		+0.72%	+26.81%

06-05	Nordic Shares Moved Upward Wednesday; Crayon Group Topped Leaders	DJ
05-31	Nordic Shares Moved Upward Friday; NEL Topped Leaders	DJ

News of the index components

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' GMAB	05-15	MT
Danske Bank A/S : Insider tranaction disclosure no. 51 DANSKE	05-15	PU
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	05-15	GL
Danske Bank A/S : Code of Conduct policy DANSKE	05-15	PU
Danske Bank A/S : Active Ownership Report 2023 DANSKE	05-15	PU
Pandora A/S : launches new collection, ESSENCE PNDORA	05-15	PU
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons NOVO B	05-15	GL
COLOPLAST : Multiple silver linings in spite of a soft Q2 24 COLO B	05-15
Update regarding remediation of errors in Danske Bank's debt collection systems DANSKE	05-15	AQ
Novo Nordisk Owner to Buy Controlling Stake in Single Use Support NOVO B	05-15	MT
NOVO NORDISK : UBS sticks Neutral NOVO B	05-15	ZD
Novo Nordisk owner buys majority stake in Austrian life science tools company NOVO B	05-15	RE
No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says NOVO B	05-15	RE
Novo Nordisk's Wegovy Reduces Cardiac Events, Sustains Weight Loss, New Analysis Shows NOVO B	05-14	MT
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal NOVO B	05-14	MT
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress GMAB	05-14	BU
Genmab A/S to Present New and Updated Results from Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies At the 2024 European Hematology Association Congress GMAB	05-14	CI
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress GMAB	05-14	GL
Finnair considers issuance of new notes and announces a voluntary tender offer of its outstanding notes maturing in 2025 DANSKE	05-14	AQ
Marston's interim loss widens on impairments but sales rise CARL B	05-14	AN
NOVO NORDISK : JP Morgan reaffirms its Buy rating NOVO B	05-14	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating NOVO B	05-14	ZD
Stifel Lifts Novo Nordisk PT, Keeps Buy Recommendation NOVO B	05-14	MT
Novo Nordisk Plans First Bond Sale in Two Years NOVO B	05-14	MT
NOVO NORDISK : Stifel raises its target price NOVO B	05-14	CF
Transcript : Ambu A/S, Q2 2024 Earnings Call, May 14, 2024 AMBU B	05-14
Wegovy weight loss sustained for four years in trial, Novo Nordisk says NOVO B	05-14	RE
Notice of early redemption DANSKE	05-14	AQ
Danske Bank A/S : Impartial investigation of Danske Bank A/S’ debt collection - Report no. 5 DANSKE	05-14	PU
Coloplast expands its Luja™ portfolio with next generation catheter for women COLO B	05-14	GL
Novo Nordisk Taps Banks for Potential Bond Issue NOVO B	05-14	MT
Danske Bank A/S : Insider transaction disclosure no. 50 DANSKE	05-14	PU
Danske Bank A/S : Insider transaction disclosure no 50 DANSKE	05-14	PU
Danske Bank A/S, transactions by persons discharging managerial responsibilities DANSKE	05-14	GL
Ambu A/S : INTERIM REPORT FOR Q2 2023/24 AND THE HALF-YEAR AMBU B	05-14	PU
Novo Nordisk Reports Positive Results from Trial of Mim8 for Hemophilia A Treatment NOVO B	05-14	MT
Ambu A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 AMBU B	05-14	CI
Wegovy weight loss sustained for four years in trial, Novo Nordisk says NOVO B	05-13	RE
Ambu A/S : Q2 presentation file AMBU B	05-13	PU
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US NOVO B	05-13	MT